How to Get Myozyme (Alglucosidase Alfa) Covered by Blue Cross Blue Shield in New York: Appeals Guide and State Protections
Answer Box: Getting Myozyme Covered by Blue Cross Blue Shield in New York
Blue Cross Blue Shield in New York requires prior authorization for Myozyme (alglucosidase alfa) with confirmed Pompe disease diagnosis and specialist involvement. The fastest path to approval: (1) Ensure your metabolic/genetic specialist has documented enzyme deficiency and GAA gene mutations, (2) Submit the complete BCBS medical drug prior authorization form with all required clinical documentation, and (3) If denied, file an internal appeal within 60 days, then pursue New York's external review through the Department of Financial Services if needed. New York offers strong patient protections with binding external appeals and expedited timelines for urgent cases.
Table of Contents
- Understanding the Denial: Decode Your BCBS Letter
- Fixable Causes: Common Issues and Quick Solutions
- First-Level Appeal: Building Your Case
- Peer-to-Peer Call Strategy
- New York External Review Process
- Appeal Templates and Scripts
- Tracking Your Case
- Strengthening Your Appeal
- If All Appeals Fail: Alternative Options
- FAQ
Understanding the Denial: Decode Your BCBS Letter
When Blue Cross Blue Shield denies Myozyme coverage, the denial letter will specify the reason using standardized codes. The most common denial reasons include:
Medical Necessity Issues:
- Incomplete Pompe disease diagnostic confirmation
- Missing enzyme (GAA) activity testing results
- Absence of genetic testing showing GAA gene mutations
- Lack of specialist evaluation or documentation
Administrative Issues:
- Missing prior authorization request
- Incomplete clinical documentation
- Wrong benefit category (medical vs. pharmacy)
- Coding errors or missing ICD-10 codes
Tip: Look for the denial code and reference policy number in your letter. This tells you exactly which BCBS medical policy applies to your case.
Key Information to Extract:
- Specific denial reason and policy citation
- Appeal deadline (typically 60 days for internal appeals)
- Required forms and submission method
- Whether this affects medical or pharmacy benefits
Fixable Causes: Common Issues and Quick Solutions
Many Myozyme denials can be resolved quickly by addressing documentation gaps:
| Issue | Solution | Timeline |
|---|---|---|
| Missing enzyme testing | Request GAA activity assay results from lab | 1-2 weeks |
| No genetic confirmation | Order GAA gene sequencing if not done | 2-4 weeks |
| Specialist referral needed | Schedule with metabolic/genetic specialist | 2-6 weeks |
| Wrong diagnosis codes | Verify ICD-10 codes with billing department | 1-3 days |
| Incomplete prior auth form | Resubmit with all required sections completed | 3-5 days |
Note: BCBS typically requires both enzyme deficiency documentation AND genetic testing confirmation for Pompe disease medical necessity determination.
First-Level Appeal: Building Your Case
Required Documentation Checklist
Your internal appeal to BCBS should include:
Clinical Evidence:
- ✅ GAA enzyme activity test results showing deficiency
- ✅ Genetic testing confirming GAA gene mutations
- ✅ Specialist evaluation letter (metabolic, genetic, or neurology)
- ✅ Current functional assessments (6-minute walk test, FVC)
- ✅ Treatment history and response documentation
Administrative Items:
- ✅ Completed BCBS appeal form
- ✅ Copy of original denial letter
- ✅ Patient insurance information
- ✅ Prescriber attestation of medical necessity
Medical Necessity Letter Framework
Your specialist should address these key points:
- Confirmed Diagnosis: "Patient has laboratory-confirmed Pompe disease with GAA enzyme deficiency of [specific value] and pathogenic GAA gene mutations [specify variants]."
- Clinical Rationale: Reference FDA labeling showing Myozyme improves ventilator-free survival in infantile-onset Pompe disease.
- Specialist Expertise: Establish the prescriber's qualifications in metabolic or genetic disorders.
- Monitoring Plan: Detail infusion schedule (20 mg/kg every 2 weeks) and safety monitoring protocols.
Peer-to-Peer Call Strategy
Request a peer-to-peer review if your initial appeal is denied. This allows your specialist to speak directly with a BCBS medical director.
Preparation Checklist:
- Schedule through BCBS provider services
- Prepare 5-minute summary of key clinical points
- Have all test results and documentation ready
- Focus on FDA-approved indications and dosing
Key Talking Points:
- Confirmed Pompe disease diagnosis with both enzyme and genetic testing
- FDA approval specifically for improved ventilator-free survival
- Specialist oversight and appropriate infusion center capabilities
- Patient's current functional status and treatment goals
New York External Review Process
New York offers robust patient protections through the Department of Financial Services (DFS) external appeal process.
Timeline and Process
| Step | Deadline | Decision Timeline |
|---|---|---|
| Internal appeal to BCBS | 60 days from denial | 30 days |
| External appeal to DFS | 4 months from final denial | 30 days (standard) |
| Expedited external appeal | 4 months from final denial | 72 hours |
| Urgent drug appeals | 4 months from final denial | 24 hours |
How to File External Appeal
- Complete the New York State External Appeal Application (download from DFS website)
- Attach required documents:
- BCBS final adverse determination letter
- All previous appeal decisions
- Supporting medical documentation
- Physician letter explaining medical necessity
- Submit to DFS:
- Mail: 99 Washington Avenue, Box 177, Albany, NY 12210
- Fax: (800) 332-2729
- For expedited appeals, also call (888) 990-3991
Important: About 45% of external appeals in New York overturn prior denials, making this a valuable option if internal appeals fail.
Appeal Templates and Scripts
Patient Phone Script for BCBS
"Hello, I'm calling about a denial for Myozyme for my confirmed Pompe disease. I have my policy number [X] and the denial reference [Y]. I need to understand the specific medical policy requirements and how to submit an internal appeal. Can you also tell me if this requires medical or pharmacy benefit prior authorization?"
Email Template for Clinical Documentation
Subject: Urgent - Myozyme Appeal Documentation Needed
"Dear [Specialist Name],
I need your help preparing an appeal for my Myozyme denial from Blue Cross Blue Shield. Could you please provide:
- A letter confirming my Pompe disease diagnosis with specific enzyme and genetic test results
- Medical necessity justification referencing FDA labeling
- Your qualifications as a metabolic/genetic specialist
- Current functional assessment results
The appeal deadline is [date]. Thank you for your assistance."
Tracking Your Case
Appeal Log Template
| Date | Action | Submitted To | Reference # | Follow-up Date |
|---|---|---|---|---|
| [Date] | Internal appeal filed | BCBS | [Ref #] | [Date + 30 days] |
| [Date] | Additional docs sent | BCBS | [Ref #] | [Date + 7 days] |
| [Date] | External appeal filed | NY DFS | [Case #] | [Date + 30 days] |
When to Escalate
Contact New York regulators if:
- BCBS misses appeal deadlines
- Required forms are not provided
- Denial reasons are unclear or contradictory
New York Department of Financial Services:
- Consumer Helpline: (800) 342-3736
- Online complaint portal available at dfs.ny.gov
Strengthening Your Appeal
Key Evidence to Include
Clinical Guidelines: Reference FDA labeling showing Myozyme's proven efficacy in infantile-onset Pompe disease with improved ventilator-free survival compared to historical controls.
Specialist Credentials: Ensure your prescriber's qualifications in metabolic, genetic, or neuromuscular disorders are clearly documented.
Diagnostic Certainty: Include both enzyme activity results and genetic testing confirmation - BCBS typically requires both for medical necessity.
Safety Monitoring: Document appropriate infusion center capabilities and monitoring protocols for managing potential anaphylaxis and infusion reactions.
If All Appeals Fail: Alternative Options
Manufacturer Support Programs
Sanofi Patient Assistance: Contact Sanofi's patient support program to explore financial assistance options and alternative access pathways.
State Programs
New York Medicaid: If eligible, New York Medicaid may provide coverage with different criteria than commercial BCBS plans.
Clinical Trial Access
Research Participation: Explore clinical trials through ClinicalTrials.gov for investigational treatments or expanded access programs.
At Counterforce Health, we help patients navigate complex insurance denials by creating targeted, evidence-backed appeals that address payers' specific requirements. Our platform analyzes denial letters and crafts point-by-point rebuttals using the right clinical evidence and procedural requirements for each payer and state.
FAQ
How long does BCBS prior authorization take in New York? Standard prior authorization decisions are typically issued within 14 days, while urgent requests receive responses within 72 hours.
What if Myozyme is non-formulary on my BCBS plan? You can request a formulary exception with supporting clinical documentation. If denied, New York's external appeal process provides an independent medical review.
Can I request an expedited appeal? Yes, if delay threatens your health or if you're currently using the medication and interruption poses significant risk. A prescriber's attestation is required.
Does step therapy apply to Myozyme? Step therapy protocols generally do not apply for established Pompe disease patients, but may be required for new starts. Document any contraindications to alternatives.
What happens if I miss my appeal deadline? Contact BCBS immediately to request deadline extension based on good cause. New York law provides some protections for missed deadlines due to circumstances beyond your control.
How much does the external appeal cost? New York charges a maximum $25 fee per external appeal, waived for financial hardship or Medicaid enrollees.
Sources & Further Reading
- New York State External Appeal Application (PDF)
- FDA Myozyme Prescribing Information
- New York Department of Financial Services Consumer Assistance
- Community Health Advocates Helpline - 888-614-5400
- Counterforce Health - Insurance denial appeals platform
From our advocates: We've seen cases where patients initially denied for Myozyme were approved after providing comprehensive genetic testing documentation that was missing from the original submission. The key was working with the specialist to ensure both enzyme activity and GAA gene mutation results were clearly documented in the appeal, along with the specialist's credentials in metabolic disorders.
Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan for specific guidance. Coverage policies vary by individual BCBS plan and may change over time.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.